Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKromek Share News (KMK)

Share Price Information for Kromek (KMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.85
Bid: 7.50
Ask: 8.20
Change: 0.10 (1.29%)
Spread: 0.70 (9.333%)
Open: 7.75
High: 7.90
Low: 7.58
Prev. Close: 7.75
KMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kromek awarded two extension contracts worth ?1.6m

Tue, 24th Sep 2019 11:55

(Sharecast News) - Medical, security screening and nuclear detection technology provider Kromek has been awarded two extension contracts relating to its 'D3S' family of products and technologies designed to counter nuclear terrorism, it announced on Tuesday.
The AIM-traded firm said the contracts were worth an aggregate of approximately £1.6m, and would be delivered in the current financial year.

It said the US Government's Countering Weapons of Mass Destruction Office, which is a component within the US Department of Homeland Security, had awarded it a $0.7m (£0.6m) extension contract to add further technical innovation capability to the D3S family of products.

The enhancements would provide greater operational capability by improving user experience, the board explained, and add a specialised reporting function to generate further information for homeland security organisations.

It was also awarded a £1.0m contract extension by a European government-related company, to provide integration of its D3S-related technologies.

The customer was a company that worked with a European government to detect and protect against potential nuclear threats, with the group's solutions set to be used for wide-area threat monitoring.

That brought the total awarded by the customer during the financial year to £2.1m.

"The D3S family of products is gaining increasing momentum globally, with sales in 18 countries, as governments continue to adopt innovative solutions for countering the threat of nuclear terrorism," said chief executive officer Arnab Basu.

"We are also pleased to be receiving further orders from existing customers, which reflects the value that they gain from our solutions. With some of our multi-year trials approaching a successful conclusion, we look forward to additional product and system-level sales of this leading-edge solution in the future."
More News
1 Oct 2014 07:31

UK MORNING BRIEFING: Supermarkets Lead FTSE Lower On Sainsbury Sales

Read more
1 Oct 2014 05:19

UK AGM, EGM Calendar - Week Ahead

Read more
30 Sep 2014 15:18

UK AGM, EGM Calendar - Week Ahead

Read more
30 Sep 2014 05:23

UK AGM, EGM Calendar - Week Ahead

Read more
29 Sep 2014 14:58

UK AGM, EGM Calendar - Week Ahead

Read more
29 Sep 2014 05:21

UK AGM, EGM Calendar - Week Ahead

Read more
26 Sep 2014 14:25

UK AGM, EGM Calendar - Week Ahead

Read more
26 Sep 2014 05:22

UK AGM, EGM Calendar - Week Ahead

Read more
25 Sep 2014 15:14

UK AGM, EGM Calendar - Week Ahead

Read more
25 Sep 2014 05:24

UK AGM, EGM Calendar - Week Ahead

Read more
24 Sep 2014 15:18

UK AGM, EGM Calendar - Week Ahead

Read more
22 Sep 2014 08:28

Kromek Gets USD1 Million Payment As Development Programme Progresses

Read more
9 Sep 2014 10:26

Amphion Innovations Agrees Terms For Additional Draws On Loan Facility

Read more
28 Aug 2014 12:17

Kromek Group Widens Pretax Loss On Listing Costs

Read more
28 Aug 2014 09:24

Thursday broker round-up UPDATE

Antofagasta: Investec lowers target price from 720p to 719p and retains a sell recommendation. Arrow Global: Canaccord Genuity moves target price from 318p to 325p and keeps a buy recommendation. Numis downgrades from buy to add with a target price of 285p. Balfour Beatty: Berenberg moves target p

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.